AGE formation blockade with aminoguanidine does not ameliorate chronic allograft nephropathy

Christoph Schmaderer*, Chang Jiang Xing, Gaby Anderson, Rob Hermans, Jens Lutz, Uwe Heemann, Marcus Baumann

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)349-354
JournalLife Sciences
Volume89
Issue number11-12
DOIs
Publication statusPublished - 12 Sep 2011

Keywords

  • Kidney transplantation
  • Advanced glycation end products
  • Aminoguanidine
  • N(epsilon)-carboxymethyllysine (CML)

Cite this